$ITRI

Reeves Donald L. III sold $28K of ITRI

Reeves Donald L. III (SVP, Outcomes) sold 283 shares of ITRON, INC. (ITRI) at $99.99 on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Reeves Donald L. III
Published Aug 26, 2026, 5:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 5:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ITRI
Neutral
high confidence
Mentioned
$ITRI
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ITRINeutralLow
01

Why it matters

The disclosed sale is routine and small; investors are unlikely to adjust positions based solely on this filing.

02

Market read

Low relevance; the filing provides a minor data point for existing shareholders but does not constitute a trading catalyst.

03

What to watch

Potential upcoming earnings or product announcements that may change the stock's trajectory.

Relevance 2/10Novelty 4/10Timing: filing disclosed on Aug 26, 2026

Background

Itron (NASDAQ: ITRI) provides metering and data collection solutions for utilities; insider sales are regularly reported via Form 4.

Company-level read

Ticker impact

$ITRINeutralHigh confidence
Context

Officer Reeves Donald L. III sold 283 shares for $28,297 via a 10b5‑1 plan, disclosed in a Form 4 filing.

Expected impact

No significant price impact expected.

Evidence & confidence

The transaction size is small relative to float and disclosed through a routine filing; markets typically view such sales as low‑impact.

Market effects

None; the sale does not affect the utilities/technology sector broadly.

None; limited to Itron shareholders.

None; isolated insider transaction.

Counterpoint

If the insider is reducing exposure ahead of negative news, the sale could foreshadow downside.

Key entities

  • Reeves Donald L. III

    Senior Vice President, Outcomes at Itron.

  • Itron, Inc.

    US‑listed provider of smart metering and data analytics.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VIAVMed

Inspection Instruments Stocks Q2 Earnings Review: Keysight (NYSE:KEYS) Shines

Viavi Solutions (down 10.9%) had the fastest revenue growth among inspection instruments stocks, while Badger Meter (NYSE:BMI, down 9.3%) reported a 6.6% revenue decline. Itron (NASDAQ:ITRI, up 12.2%) missed revenue estimates but exceeded EBITDA and EPS guidance. Teledyne (NYSE:TDY, down 3.7%) reported a 9.8% revenue increase, beating expectations. Market risks have shifted from AI to geopolitics and back to fundamentals.

$ITRIMedAI 8/10

Why Shares of Itron Stock Jumped 17.4% This Week

Itron shares rose about 17% this week after the company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Itron posted non-GAAP EPS of $1.59 versus $1.29 expected and cited demand for grid stability tied to AI infrastructure build-out. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMed

Why Shares of Itron Stock Jumped 17.4% This Week

Itron (NASDAQ: ITRI) shares rose about 17.4% this week, after the utility technology company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Non-GAAP EPS was $1.59 versus $1.29 expected. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMedAI 8/10

Itron Q2 Earnings Call Highlights

Itron (NASDAQ:ITRI) reported Q2 GAAP net income of $53M, or $1.19/diluted share, versus $68M a year earlier. Non-GAAP operating income rose 8% to $89M and adjusted EBITDA rose 8% to $97M. Q2 revenue by segment: Device Solutions $111M, Networked Solutions $339M, Outcomes $96M, Resiliency Solutions about $16M. Free cash flow was $81M. Backlog was $4.4B. Itron raised full-year non-GAAP EPS to $6.30-$6.50 and narrowed revenue to $2.37B-$2.41B.